Surveillance and monitoring
This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).
Surveillance and monitoring
This monitoring report provides an update on the progress towards the Sustainable Development Goal (SDG) 3.3 targets and other main global and regional targets for eliminating HIV, viral hepatitis, TB and STIs as public health threats.
Overview of progress towards the Sustainable Development Goal 3.3 targets on HIV, tuberculosis, viral hepatitis and sexually transmitted infections in the EU/EEA, 2025
English (2.53 MB - PDF)
Surveillance and monitoring
Although preventable, HIV, tuberculosis (TB), viral hepatitis and sexually transmitted infections (STIs) remain public health issues in the European Union and European Economic Area (EU/EEA), causing substantial morbidity and nearly 59 000 deaths annually – 90% of which are due to hepatitis B and C.
Evidence brief: Overview of progress towards the Sustainable Development Goal 3.3 targets on HIV, tuberculosis, viral hepatitis and sexually transmitted infections in the EU/EEA, 2025
English (2.19 MB - PDF)
Assessment
As of 6 May 2026, seven cases have been reported in a hantavirus-associated cluster of illness on a cruise ship, including three deaths, one critically ill, two symptomatic and one with unknown status.
Hantavirus-associated cluster of illness on a cruise ship: ECDC assessment and recommendations
English (403.61 KB - PDF)
Public health guidance
This guidance underscores the need to establish and sustain IPC programmes at national and healthcare facility levels in the EU/EEA and is intended to be adapted by national authorities to their specific legal and organisational contexts, considering the heterogeneity of health systems.
Proposal for EU guidance on the establishment and implementation of infection prevention and control programmes in healthcare
English (1.6 MB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25-30 April 2026, and includes updates on influenza, cholera, chikungunya virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
Communicable disease threats report, 25-30 April 2026, Week 18
English (1.52 MB - PDF)
Surveillance and monitoring
This report presents data on mpox cases reported to the European Surveillance System (EpiPulse Cases). EU/EEA countries report case based data to ECDC on diagnosed mpox cases. For case numbers by countries, Western Balkans and Türkiye are included.
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 April 2026, and includes updates on avian influenza, Salmonella Bovismorbificans, and an overview of respiratory virus epidemiology in the EU/EEA.
Communicable disease threats report, 18-24 April 2026, Week 17
English (1.42 MB - PDF)
Surveillance and monitoring
In 2023, 24 567 confirmed cases of invasive pneumococcal disease (IPD) were reported in the European Union/European Economic Area.
Invasive pneumococcal disease - Annual Epidemiological Report for 2023
English (884.99 KB - PDF)
Surveillance and monitoring
This report monitors the policy objectives set out by the Council Recommendation on vaccine-preventable cancers.
The State of Health of HPV vaccination programmes in the EU/EEA
English (2.96 MB - PDF)
Surveillance and monitoring
In 2024, 209 674 cases of pertussis were reported by 29 EU/EEA countries.
Pertussis Annual Epidemiological Report for 2024
English (1.21 MB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 April 2026, and includes updates on respiratory virus epidemiology in the EU/EEA, measles, zika, and chikungunya.
Communicable disease threats report, 12-18 April 2026, Week 16
English (1.3 MB - PDF)
Operational support
This reporting protocol is for the 2026 data call for antimicrobial resistance (AMR) surveillance data, collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2025.
European Antimicrobial Resistance Surveillance Network (EARS-Net) surveillance data for 2025
English (1.93 MB - PDF)
Assessment
ECDC cooperates with countries under the EU enlargement policy to improve their infectious disease prevention and control systems and public health workforce and prepare them for their future participation in ECDC’s work.
ECDC review of communicable disease surveillance in Ukraine
English (324.85 KB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 April 2026, and includes updates on avian influenza, dengue, and an overview of respiratory virus epidemiology in the EU/EEA.
Communicable disease threats report, 4-10 April 2026, Week 15
English (2.07 MB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 March-3 April 2026 and includes updates on SARS-CoV-2 variant classification, Middle East respiratory syndrome coronavirus (MERS-CoV), cholera, HIV, and avian influenza.
Communicable disease threats report, 28 March – 3 April 2026, Week 14
English (5.14 MB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, chikungunya, dengue, avian influenza, invasive meningococcal disease, aedes aegypti detection in Luxembourg, and measles.
Communicable disease threats report, 21 – 27 March 2026, Week 13
English (3.67 MB - PDF)
Operational support
In-action reviews (IARs) and after-action reviews (AARs) – referred to collectively in this guide as ‘action reviews’ – provide a structured way to capture and act on the lessons learned during an ongoing or past public health emergency response.
Guide for designing and conducting in-action and after-action reviews
English (5.86 MB - PDF)
Surveillance and monitoring
Overview of the tuberculosis situation in Europe, public health challenges, goals, and ECDC actions to tackle the disease.
Operational support
Tuberculosis (TB) is a major cause of morbidity and mortality in Europe. High-quality laboratory diagnosis of TB is the basis for both individual patient treatment and surveillance.
Handbook on tuberculosis laboratory diagnostic methods in the European Union - updated 2026
English (5.31 MB - PDF)
Surveillance and monitoring
This report provides an overview of the latest TB epidemiological situation. It is published jointly by the WHO Regional Office for Europe and the European Centre for Disease Prevention and Control.
Tuberculosis surveillance and monitoring in Europe 2026 - 2024 Data
English (17.31 MB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14 -20 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, mass gathering monitoring, avian influenza, dengue, serious adverse events to IXCHIQ chikungunya virus disease vaccine, and invasive meningococcal disease.
Communicable disease threats report, 14 - 20 March 2026 , week 12
English (1.98 MB - PDF)
Surveillance and monitoring
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 March 2026 and includes updates on respiratory virus epidemiology in the EU/EEA, measles, chikungunya, mass gathering monitoring, and mpox.
Communicable disease threats report, 7 – 13 March 2026 , week 11
English (1.18 MB - PDF)
Surveillance and monitoring
Between 29 November 2025 and 27 February 2026, 2514 highly pathogenic avian influenza (HPAI) A(H5) virus detections were reported in domestic (406) and wild (2108) birds in 32 countries in Europe.
Avian influenza overview December 2025–February 2026
English (1.94 MB - PDF)
Operational support
This Reporting Protocol describes data collection for influenza, COVID-19, and other respiratory viruses (such as RSV or new viruses of public health concern) in the EU/EEA and wider WHO European Region. Data collection is integrated for most datasets in line with the operational considerations for respiratory virus surveillance in Europe.
Reporting Protocol for integrated respiratory virus surveillance, version 1.12
English (1.56 MB - PDF)